DIP Episode 192 - Updated USMLE Step 1 Endocrine Review Series 2 (Adrenals, complete)

Source / episode info

• Episode: 192
• Title: Divine Intervention Episode 192 – Updated USMLE Step 1 Endocrine Review Series 2 (Adrenals, complete).
• Published: 2019-12-12
• Source: Episode page

One-liner

This episode provides a comprehensive review of hypercortisolism workup (Cushing syndrome), primary and secondary mineralocorticoid excess (Conn Syndrome), adrenal tumor differentiation (Neuroblastoma vs. WHO Ms), and the management principles for pheochromocytoma.

High-yield summary

• Cushing Syndrome Workup: Initial screening involves elevated 24-hour urinary free cortisol or failure to suppress morning cortisol with low-dose dexamethasone. ACTH levels determine if the cause is adrenal (low ACTH) or pituitary/ectopic (high ACTH).
• Primary Hyperaldosteronism (Conn Syndrome): Characterized by resistant hypertension, hypokalemia, metabolic alkalosis, and an elevated plasma Aldosterone/Plasma Renin Ratio (ARR). Diagnosis confirmation requires failure to suppress aldosterone with saline infusion.
• Neuroblastoma vs. WHO Ms: Neuroblastomas are neurogenic tumors that classically cross the midline and tend to be calcified; they present with paraneoplastic syndromes like oculo-motor clonus and myoclonus. WHO Ms do not typically cross the midline.
• Pheochromocytoma Management: Preoperative management requires blocking alpha receptors first (e.g., Phenoxybenzamine) before administering beta-blockers to prevent precipitous blood pressure drops.
• Adrenal Tumors: Adrenal adenomas are often non-functional, while adrenal carcinomas usually hypersecrete multiple hormones (cortisol, aldosterone, sex steroids).

Learning objectives

• Differentiate the diagnostic workup flow for Cushing syndrome based on ACTH levels.
• Identify the classic biochemical triad (hypertension, hypokalemia, metabolic alkalosis) associated with mineralocorticoid excess.
• Distinguish between primary and secondary causes of hyperaldosteronism using plasma renin activity measurements.
• Recognize the characteristic physical exam findings and imaging features that differentiate neuroblastoma from WHO Ms.
• Outline the critical sequence for pre-operative management of pheochromocytoma.

Board exam buzzwords

Rapid review table

Board-speak -> diagnosis

Differential diagnosis / distinguishing features

Adrenal Adenoma vs Adrenal Carcinoma

Neuroblastoma vs WHO Ms

Management pearls

• For resistant hypertension due to hyperaldosteronism, use a mineralocorticoid receptor antagonist (e.g., Spironolactone or Eplerenone) rather than loop/thiazide diuretics.
• When managing pheochromocytoma, always initiate with an alpha-blocker (Phenoxybenzamine) for 12–24 hours before adding beta-blockers to prevent hypertensive crisis.
• In the workup of Cushing syndrome, if ACTH is high and the High Dose DST fails to suppress cortisol, suspect ectopic ACTH production (e.g., small cell lung cancer).
• For adrenal tumors, surgical removal often involves removing the entire gland on that side due to potential for functional or malignant overgrowth.

Don't miss

Integration & clinical reasoning

• Endocrine/Renal Integration: The RAAS system is the primary regulator of blood pressure and volume status; understanding how aldosterone excess (Conn Syndrome) disrupts potassium and acid-base balance is critical for managing resistant hypertension.
• Oncology/Adrenal Integration: Adrenal tumors are highly variable: adenomas are often benign, while carcinomas are frequently malignant and hormonally active. The differential diagnosis between neuroblastoma and WHO Ms requires careful consideration of midline crossing and calcification patterns.
• Pharmacology/Endocrine Integration: Mineralocorticoid receptor antagonists (Spironolactone) block the effects of excess aldosterone, making them superior to standard diuretics in treating primary hyperaldosteronism.

OMM / COMLEX integration

• Acute Adrenal Crisis/Adrenal Insufficiency: In any unstable patient (e.g., septic shock, trauma) suspected of adrenal insufficiency, administer IV hydrocortisone immediately; do not wait for definitive testing.
• Pheochromocytoma in Acute Setting: If a patient is critically ill and requires catecholamine management (e.g., vasopressors), assume pheochromocytoma until proven otherwise and manage with alpha blockade first.

Concept connections / cross-references

• For general endocrine workups and pituitary function: Divine Intervention Episode 191.
• For understanding adrenal gland anatomy and vascular supply: Review previous episodes on renal/vascular anatomy.

High-yield association table

Key terms glossary

Study optimization

Question pattern recognition

• The "First Step" Pattern: Always determine the initial screening test (e.g., 24h UFC or LDDST) before proceeding to confirmatory tests in endocrine disorders.
• The Differential Diagnosis Trap: Be prepared to differentiate between two similar-sounding tumors/conditions based on subtle, high-yield physical exam findings (e.g., midline crossing, calcification).
• The Management Sequence Pattern: For acute crises or pre-operative states (Pheo), the order of drug administration is paramount and must be memorized.

Test yourself

Common mistakes to avoid

Common traps